Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_provenance.
- NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_assertion description "[The 5-month-old 5XFAD mice, which carry five familial AD mutations in the ?-amyloid precursor protein (APP) and presenilin-1 (PS1) genes, were treated with triptolide for 8 weeks.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_provenance.
- NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_assertion evidence source_evidence_literature NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_provenance.
- NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_assertion SIO_000772 25481013 NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_provenance.
- NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_assertion wasDerivedFrom befree-2016 NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_provenance.
- NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_assertion wasGeneratedBy ECO_0000203 NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1245399.RA5G3tZ5uLrhwzrfqa4Tpu0NYYopqDnt8tDYn1meNzQqE130_provenance.